Indivior Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
INDV Nasdaq 2830 www.indivior.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Indivior Pharmaceuticals, Inc.

Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ - Jan 28th, 2026 5:00 am
Indivior Announces Completion of Redomiciliation to the United States - Jan 26th, 2026 5:00 am
Strength Seen in Ardelyx (ARDX): Can Its 15.0% Jump Turn into More Strength? - Jan 21st, 2026 5:17 am
Indivior’s 2026 Revenue Guidance Tightens Expectations Might Change The Case For Investing In Indivior (INDV) - Jan 21st, 2026 2:10 am
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes - Jan 13th, 2026 7:19 am
PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates - Jan 12th, 2026 8:14 am
Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus - Jan 12th, 2026 6:43 am
Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance - Jan 10th, 2026 12:57 pm
Indivior (NasdaqGS:INDV) Valuation Check After Strong Long Term Returns And Recent Price Consolidation - Jan 9th, 2026 10:13 pm
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations - Jan 9th, 2026 9:46 am
GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug - Jan 8th, 2026 9:09 am
4 Stocks Trading Near 52-Week High With Room to Rise Further - Jan 8th, 2026 6:57 am
Indivior Provides Full-Year 2026 Financial Guidance and Business Update - Jan 8th, 2026 5:00 am
Is Indivior (NasdaqGS:INDV) Still Attractive After A 192% One Year Share Price Jump - Jan 7th, 2026 3:14 pm
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug - Jan 7th, 2026 9:45 am
OTLK Stock Crashes 67% in a Week: Here's What You Need to Know - Jan 7th, 2026 7:53 am
ALT Stock Up 17% After Pemvidutide Gets FDA Breakthrough Tag for MASH - Jan 6th, 2026 9:53 am
Why This Top 100 Stock to Buy Is Getting Cheaper Even as It Soars Higher - Dec 30th, 2025 8:32 am
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table - Dec 28th, 2025 10:56 am
Indivior (NasdaqGS:INDV): Revisiting Valuation After S&P SmallCap 600 Inclusion and Strong Recent Share Price Gains - Dec 23rd, 2025 6:10 pm